Earnings call transcript: Stellus Capital’s Q1 2026 EPS meets forecast, revenue misses

Stellus Capital reported Q1 2026 EPS of $0.26 in line with estimates, but revenue missed at $23.29 million versus $24.91 million expected, and NAV fell $0.28 per share. Shares dropped 3.69% to $9.39 after earnings and are down 25% year-to-date, with non-accrual loans rising to six positions representing 5.2% of fair value. Management guided to a lower dividend over time, while also highlighting a $20 million buyback authorization and potential portfolio growth of $75 million-$100 million.

Analysis

The market is keying less on the headline earnings print and more on what it implies about BDC duration risk: if underwriting is holding but fee income and NII power are not expanding, the next leg is usually dividend normalization, not multiple expansion. That matters because the current discount to NAV is now doing double duty — it supports buybacks mechanically, but it also signals the market is pricing a lower run-rate payout and slower asset growth. The Ridgepost tie-up is the only credible offset here, but it is an execution story with a lag; the near-term winners are likely the acquirer platform and any lenders to sponsor-backed lower middle market borrowers that can absorb incremental deal flow.

The second-order risk is that elevated non-accruals and flat portfolio size reduce the compounding engine right when spreads are only stabilizing rather than widening. In a benign macro, this is manageable; in a slower economy, it becomes a denominator problem: less earning assets, lower NII, and more pressure to defend the dividend via portfolio rotation or payout cuts. The buyback is constructive but not a cure — repurchasing stock at a discount only creates value if asset quality does not deteriorate further, and any credit event that forces NAV lower would erase most of the capital return benefit.

Consensus likely underestimates how much of the valuation thesis depends on a re-acceleration that is at least two quarters away. The stock can remain cheap for a long time if the market concludes earnings power has plateaued and the dividend must reset lower first. The contrarian angle is that the downside may already be partly reflected in the discount to NAV, so the cleaner short is not the common itself but a basket of other BDCs with weaker balance sheets and less room for buybacks; SCM’s liquidity and leverage flexibility reduce insolvency risk even if near-term growth is mediocre.

Key Decisions for Investors

• Long SCM only as a trading position into buyback execution and Ridgepost milestones (30-90 days); target a 5-8% rebound if repurchases begin and credit does not worsen, but cut if NAV continues to slide.
• Avoid owning SCM for income until dividend reset risk is resolved; if held in a yield portfolio, hedge with short-dated puts or reduce size ahead of the next ex-dividend cycle.
• Pair trade: long higher-quality, lower-discount BDCs with cleaner non-accrual trends against short a basket of more levered, lower-NAV-coverage names; SCM is a relative outperformer only if the market rewards balance sheet flexibility.
• Sell volatility into any post-earnings bounce by writing covered calls on SCM over the next 1-2 months; the catalyst path is slow and the stock is more likely to grind than rerate sharply.
• Watch for a pair-trade reversal into late Q3: if SCM shows non-accrual resolution and buyback activity, rotate from short to long versus peers with no capital return program and weaker sponsor origination channels.